Amyris announces operational and financial restructuring to advance strategic transformation

Voluntary chapter 11 commenced to finalize consensual go-forward plan for amyris' core business $190 million financing commitment from foris ventures to support day-to-day operations emeryville, calif. , aug. 9, 2023 /prnewswire/ -- amyris, inc. (nasdaq: amrs) ("amyris" or the "company"), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its lab-to-market™ technology platform and clean beauty consumer brands, today announced that it is moving forward with an operational and financial restructuring to further advance its ongoing strategic transformation and position the company for long-term success.
AMRS Ratings Summary
AMRS Quant Ranking